Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px
Document › Details

Eppendorf AG. (4/28/17). "Press Release: Fiscal year 2016 – Eppendorf Continues on Course for Success". Hamburg.

Organisations Organisation Eppendorf AG
  Group Eppendorf (Group)
  Organisation 2 Bio-ITech B.V.
  Group Eppendorf (Group)
Products Product laboratory equipment and instruments
  Product 2 device software
Index term Index term Bio-ITech–Eppendorf: investment, 2017Q1 acquisition of majority share in Bio-ITech BV by Eppendorf
Persons Person Bachmann, Thomas (Eppendorf 201508– CEO before Pesident of Bruker BioSpin Group + Tecan CEO)
  Person 2 Brahms, Julie (Eppendorf 201604 Public Relations)
     


> Group sales of €651.5 million (revenue growth of 4.8% in local currencies)

> Income from operations of €139.6 million. (EBIT margin of 21.4%)


The Eppendorf Group successfully ended fiscal year 2016 with Group sales of €651.5 million (prior year: €629.1 million) and revenue growth of 3.6% (4.8% when adjusted for currency effects). Income from operations (EBIT) climbed 17.1% to €139.6 million (prior year: €119.3 million), amounting to an EBIT margin of 21.4% (prior year: 19.0%).

The Asian market and the services segment in particular contributed to this good result. During the reporting year, Eppendorf significantly increased expenses for research and development to €34.8 million (prior year: €31.9 million). In addition, the company expanded its global service and sales presence, among other things through the acquisition of a company in Ireland.

“Once again, we can look back on a good fiscal year. We want to continue developing dynamically and are currently working on a variety of measures to ensure we achieve profitable growth in the future as well,” said Thomas Bachmann, President & Chief Executive Officer of Eppendorf AG. “In addition to carrying out various internal projects, we took the step early this year, for instance, of acquiring a controlling interest in the Dutch company Bio-ITech B.V. after working closely with them last year on device and data networking.”

In 2017, the company will continue to focus on product and application development as well as on the ongoing expansion of its sales, development and production sites.

You will find the Eppendorf AG 2016 Annual Report at: corporate.eppendorf.com/en/company/annual-report/


About Eppendorf AG:

Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid handling, sample handling, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers, and DNA amplification equipment as well as ultra-low temperature freez-ers, fermentors, bioreactors, CO2 incubators, shakers, and cell manipulation systems. Consuma-bles such as pipette tips, test tubes, microliter plates, and single-use bioreactor vessels com-plement the range of highest-quality premium products.

Eppendorf products are most broadly used in academic and commercial research laboratories, e.g., in companies from the pharmaceutical and biotechnological as well as the chemical and food industries. They are also aimed at clinical and environmental analysis laboratories, foren-sics, and at industrial laboratories performing process analysis, production, and quality assur-ance.

Eppendorf was founded in Hamburg, Germany in 1945 and has about 3,000 employees world-wide. The company has subsidiaries in 26 countries and is represented in all other markets by distributors.


Press contact:

Julie Brahms
Barkhausenweg 1
22339 Hamburg, Germany
Phone: +49 40 538 01-616
brahms.j@eppendorf.de
Fax: +49 40 538 01-835
www.eppendorf.com

   
Record changed: 2017-05-02

Advertisement

Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

More documents for Eppendorf (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px




» top